Skip to content

Top 5 stories on HIV in the US from CROI 2024

Professor Annie Luetkemeyer and Dr Hyman Scott, researchers on the doxyPEP studies, at CROI 2024. Photo by Liz Highleyman.

Over 30 years, big fall in HIV among people who inject drugs in Baltimore, but hepatitis C remains high

Yellow containers of syringes at a needle exchange in Melbourne, Australia.

Top 5 stories on co-morbidities affecting people with HIV from CROI 2024

Dr Jordan Lake at CROI 2024. Photo by Roger Pebody.

Semaglutide improves fatty liver disease and inflammation in people with HIV

Dr Jordan Lake at CROI 2024. Photo by Roger Pebody.

Heavy drinking, metabolic disorders and hepatotoxic antiretrovirals are risk factors for chronic liver disease in UK cohort

SatyaPrem/Pixabay

Breaking down the silos: integrating hepatitis C 'test and treat' services into ART clinics is possible

Chukwuemeka Agwuocha presenting at IAS 2023.

People with HIV have greater risk of ill health than others after hepatitis C cure

Mareike Günsche | www.aspect-us.com

Emergency department opt-out testing is revolutionising HIV and hepatitis diagnosis in England

Dr Rachel Hill-Tout presenting at BHIVA 2023. Photo by Roger Pebody.

80% fall in hepatitis C among people with HIV in England, British HIV Association conference hears

Dr James Lester presenting at BHIVA 2023.